Popular search terms:
CSL's Annual Report
CSL operates its fiscal year from 1 July to 30 June. Please click to view our most recent Annual Report and Key Business Highlights.
Read Our Annual Report on CSL.comSearch Results
126 results found-
Five Year Summary
CSL's exceptionally strong performance is a result of the focused execution of our strategy. Learn more.
https://www.csl.com/investors/financial-results-and-information/five-year-summary -
CSL Limited is a global biotherapy industry leader.
CSL Limited is a global biotechnology manufacturer that researches, develops, and markets products to treat and prevent rare and serious diseases. Learn more.
https://www.csl.com/ -
Financial Results and Information | CSL Limited
CSL's exceptionally strong performance is a result of the focused execution of our strategy. Learn more.
https://www.csl.com/investors/financial-results-and-information -
Driven by Our Promise TM
130 CSL Limited Annual Report 2019 CSL Limited Annual Report 2019 131 Notes to the Financial Statements
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2019-full.pdf -
4D
Accordingly, this report is to be read in conjunction with the Annual Report for the year ended 30 June 2018 and any public announcements made by CSL Limited during the interim reporting period in accordance with the continuous disclosure requirements of the Corporations Act 2001.
https://www.csl.com/-/media/shared/documents/results/2019-hy-asx.pdf -
Month 00, 0000
I hope that you have taken the opportunity to read our most recent Annual Report, copies of which are available here and also on CSL's website.
https://www.csl.com/-/media/csl/agm-assets/agm-documents/2018-csl-agm-chairmans-address.pdf -
CSL Limited ABN: 99 051 588 348 ASX Full-year information 30 June 2019 Lodged with the ASX under Listing Rule 4.3A.
We obtained the Directors' Report that is to be included in the Annual Report, prior to the date of this auditor's report, and we expect to obtain the remaining sections of the Annual Report after the date of this auditor's report.
https://www.csl.com/-/media/shared/documents/results/2019-fy-asx.pdf -
Charter of Audit and Risk Management Committee
e) a statement to the Board for inclusion in the annual report as to whether the ARMC is satisfied that the provision of any non-audit services is compatible with the independence of the external auditor and (
https://www.csl.com/-/media/csl/documents/csl-governance-docs/armc-charter.pdf -
Investor Relations | CSL Limited
CSL is a global biotech leader. We do business in over 60 countries, with major facilities around the world. Learn more.
https://www.csl.com/investors